News

Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars

Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE: 532523, NSE: ...

Algonomy's Active Content Works Alongside Grupo Comercial Chedraui to Drive Dynamic Content Personalization of its Marketing Campaigns

Algonomy, a global leader in algorithmic customer engagement, today announced the launch of Active Content, a breakthrough ...